CI Investments Inc
ALXN

CI Investments Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

CI Investments Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,900
Closed -$1.66M – 214
2016
Q1 		$1.66M Buy
+11,900
New +$1.75M 0.02% 148
2015
Q3 		– Sell
-32,100
Closed -$5.8M – 200
2015
Q2 		$5.8M Buy
+32,100
New +$5.54M 0.06% 133

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CI Investments Inc's ALXN Position: Q2 2016 in Review

CI Investments Inc sold out of Alexion Pharmaceuticals (ALXN) in Q2 2016, closing a stake of 11,900 shares — an estimated $1.66M sold.

CI Investments Inc first reported a position in ALXN in Q2 2015 and held it in 2 quarters. The position peaked at $5.8M in Q2 2015. 533 funds tracked by Wall St. Rank hold ALXN as of Q2 2016.

  • CI Investments Inc reported no remaining Alexion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • CI Investments Inc sold 11,900 Alexion Pharmaceuticals shares in Q2 2016, an estimated $1.66M.
  • CI Investments Inc first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • CI Investments Inc's Alexion Pharmaceuticals position peaked at $5.8M in Q2 2015.
  • 533 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2016.

Based on CI Investments Inc's 13F filing for Q2 2016, filed 5 Aug 2016.